Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

by Sadetsky, Natalia, Hernandez, Alexandra, Wallick, Chris J., McKenna, Edward F., Surinach, Andy, Colburn, Dawn E.
Published in Cancer Med (2020)

A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor...

by Malhi, Vikram, Colburn, Dawn, Williams, Sarah J., Hop, Cornelis E. C. A., Dresser, Mark J., Chandra, Priya, Graham, Richard A.
Published in Cancer Chemother Pharmacol (2016)

Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

by Abou-Alfa, Ghassan K., Lewis, Lionel D., LoRusso, Patricia, Maitland, Michael, Chandra, Priya, Cheeti, Sravanthi, Colburn, Dawn, Williams, Sarah, Simmons, Brian, Graham, Richard A.
Published in Cancer Chemother Pharmacol (2017)

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

by Graham, Richard A, Hop, Cornelis E C A, Borin, Marie T, Lum, Bert L, Colburn, Dawn, Chang, Ilsung, Shin, Young G, Malhi, Vikram, Low, Jennifer A, Dresser, Mark J
Published 2012